Pharma Deals Review, Vol 2007, No 84 (2007)

Font Size:  Small  Medium  Large

Sun to Acquire Taro for US$454 M

Business Review Editor

Abstract


Sun Pharmaceuticals acquired Taro Pharmaceutical Industries, substantially expanding its product portfolio with dermatology and pediatrics generics. The deal would worth up to US$454 M to Taro.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.